Di Federico A - Search Results

1

Impact of Baseline Versus Intercurrent Steroids Administration on Upfront Chemo-Immunotherapy for Advanced Non-Small Cell Lung Cancer (NSCLC).

De Giglio A, Aprile M, Di Federico A, Sperandi F, Melotti B, Gelsomino F, Ardizzoni A. De Giglio A, et al. Among authors: di federico a. Int J Mol Sci. 2022 Sep 7;23(18):10292. doi: 10.3390/ijms231810292. Int J Mol Sci. 2022. PMID: 36142204 Free PMC article.

2

Overcoming Primary Resistance to PD-1 Inhibitor With Anti-PD-L1 Agent in Squamous-Cell NSCLC: Case Report.

Gelsomino F, Di Federico A, Filippini DM, Dall'Olio FG, Lamberti G, Sperandi F, Balacchi C, Brocchi S, Ardizzoni A. Gelsomino F, et al. Among authors: di federico a. Clin Lung Cancer. 2020 Mar;21(2):e45-e48. doi: 10.1016/j.cllc.2019.11.011. Epub 2019 Nov 20. Clin Lung Cancer. 2020. PMID: 31902695 No abstract available.

3

The EGFR Exon 19 Mutant L747-A750>P Exhibits Distinct Sensitivity to Tyrosine Kinase Inhibitors in Lung Adenocarcinoma-Letter.

Di Federico A, Filippini DM, Dall'Olio FG, Conci N, Minari R, Tiseo M, Ardizzoni A. Di Federico A, et al. Clin Cancer Res. 2020 Jan 15;26(2):518-519. doi: 10.1158/1078-0432.CCR-19-2441. Clin Cancer Res. 2020. PMID: 31941684 No abstract available.

4

Comparison of Sequential Testing and Next Generation Sequencing in advanced Lung Adenocarcinoma patients - A single centre experience.

Dall'Olio FG, Conci N, Rossi G, Fiorentino M, De Giglio A, Grilli G, Altimari A, Gruppioni E, Filippini DM, Di Federico A, Nuvola G, Ardizzoni A. Dall'Olio FG, et al. Among authors: di federico a. Lung Cancer. 2020 Nov;149:5-9. doi: 10.1016/j.lungcan.2020.08.008. Epub 2020 Sep 3. Lung Cancer. 2020. PMID: 32932213

5

Beyond EGFR, ALK and ROS1: Current evidence and future perspectives on newly targetable oncogenic drivers in lung adenocarcinoma.

Lamberti G, Andrini E, Sisi M, Rizzo A, Parisi C, Di Federico A, Gelsomino F, Ardizzoni A. Lamberti G, et al. Among authors: di federico a. Crit Rev Oncol Hematol. 2020 Dec;156:103119. doi: 10.1016/j.critrevonc.2020.103119. Epub 2020 Oct 1. Crit Rev Oncol Hematol. 2020. PMID: 33053439 Review.

6

Acute kidney injury as a possible immune-related adverse event associated with sustained complete response to BRAF and MEK inhibitors in advanced, V600E-mutated melanoma.

Di Federico A, Filippini DM, Sperandi F, Ardizzoni A, Melotti B. Di Federico A, et al. Eur J Cancer. 2021 Apr;147:58-59. doi: 10.1016/j.ejca.2021.01.026. Epub 2021 Feb 19. Eur J Cancer. 2021. PMID: 33618198 No abstract available.

7

Single-agent carboplatin in extensive disease small-cell lung cancer patient with liver failure: a case report within the experience of a single institution.

Di Federico A, Andrini E, Sisi M, Nuvola G, Lamberti G, Lenzi B, Nobili E, Gelsomino F, Ardizzoni A. Di Federico A, et al. Anticancer Drugs. 2021 Aug 1;32(7):755-757. doi: 10.1097/CAD.0000000000001057. Anticancer Drugs. 2021. PMID: 33661187 Free PMC article.

8

PD-1/PD-L1 inhibitor monotherapy or in combination with chemotherapy as upfront treatment for advanced NSCLC with PD-L1 expression ≥ 50%: Selecting the best strategy.

Di Federico A, De Giglio A, Parisi C, Gelsomino F, Ardizzoni A. Di Federico A, et al. Crit Rev Oncol Hematol. 2021 Apr;160:103302. doi: 10.1016/j.critrevonc.2021.103302. Epub 2021 Mar 19. Crit Rev Oncol Hematol. 2021. PMID: 33753247 Review.

9

IMpower 132: Is the Second Exception to the Rule No Longer an Exception?

Di Federico A, Nuvola G, Deiana C, Donati G, De Giglio A. Di Federico A, et al. J Thorac Oncol. 2021 May;16(5):e29-e30. doi: 10.1016/j.jtho.2021.01.003. J Thorac Oncol. 2021. PMID: 33896575 Free article. No abstract available.

10

Paraneoplastic vs. non-paraneoplastic anti-Hu associated dysmotility: a case series and literature review.

Rossi S, Merli E, Rinaldi R, Deleonardi G, Mastrangelo V, Sasdelli AS, Di Federico A, Guarino M, Donadio V, Pironi L, Gelsomino F, De Giorgio R, D'Angelo R. Rossi S, et al. Among authors: di federico a. J Neurol. 2022 Mar;269(3):1182-1194. doi: 10.1007/s00415-021-10577-8. Epub 2021 May 2. J Neurol. 2022. PMID: 33934212 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters